Nomura
http://www.nomura.com/Nomura (NYSE: NMR) is a global investment banking and securities firm. The firm’s operations include Domestic Retail, Global Markets, Global Investment Banking, Global Merchant Banking, and Asset Management. Nomura is headquartered in Tokyo, Japan.
Nomura is represented in the Americas by Nomura Holding America (NHA). NHA’s major divisions are Fixed Income, Investment Banking, Equities and Asset Management.
View Older Stories View More Recent Stories
-
Form 6-K NOMURA HOLDINGS INC For: Mar 28
-
Instinet Appoints Mark Kelley as Senior Equity Research Analyst Covering Internet
-
China's Jan-Feb industrial profit growth strong, but pace slows from 2017
-
Macrogenics (MGNX) Announces 4.5M Common Share Offering
-
MacroGenics Announces Proposed Public Offering of Common Stock
-
MacroGenics Announces Proposed Public Offering of Common Stock
-
Micron Technology (MU) This Time Its Different, Cycle Extending - Nomura
-
Nomura/Instinet Expects More EPS Increases for Comerica (CMA)
-
Pershing Square Holdings Announces Annual General Meeting in Guernsey
-
Freddie Mac Prices $568 Million K-Deal, K-W04, Supporting Affordable Multifamily Housing for Low- and Moderate-Income Working Families
-
Carnival Corp. (CCL): Raising PT To $82 From $80 - Nomura
-
Micron Technology (MU): Strong Earnings But PT Unchanged - Nomura
-
Nike (NKE) Appears Back On Track With North America Inflection - Nomura
-
Exelixis (EXEL) Reports Positive CHMP Opinion for CABOMETYX (cabozantinib)
-
Exelixis’ Partner Ipsen Announces Positive CHMP Opinion for CABOMETYX® (cabozantinib) for Previously Untreated Intermediate- or Poor-Risk Advanced Renal Cell Carcinoma
-
Ipsen Receives Positive CHMP Opinion for Cabometyx® (cabozantinib) for the First-Line Treatment of Adults with Intermediate- or Poor- Risk Advanced Renal Cell Carcinoma
-
Form 6-K NOMURA HOLDINGS INC For: Mar 22
-
China's banks eye capital raising, earnings lift as they shed bad loans
-
Japan firms see no BOJ tightening until 2019 or beyond 2020: Reuters poll
-
The Technology Bubble Could Be Bursting - Nomura
-
Nomura/Instinet Starts Fiat Chrysler Automobiles NV (FCAU) at Neutral
-
Nomura/Instinet Downgrades MuleSoft Inc. (MULE) to Neutral Following Acquisition
-
South Korea central bank chief unsure if wide gap with U.S. rates would be sustainable
-
In search of higher margins, Canada Goose to make more of its own luxury coats
-
BBAM and Nomura Babcock & Brown Participate in a $870 Million Combined EETC JOLCO Transaction with British Airways
-
UPDATE: Nomura/Instinet Downgrades Qorvo Inc (QRVO) to Neutral
-
BlackBerry shares rise after software security pact with Microsoft
-
Caesars Entertainment (CZR) Cutting EPS On Weather - Nomura
-
Broadcom (AVGO): Cutting PT To $300 - Nomura
-
Cheetah Mobile (CMCM): Not Out Of The Woods - Nomura
-
Oracle (ORCL): Progress On The Business Model Transition - Nomura
-
Oracle (ORCL) volatility elevated into downgrades
-
Nomura/Instinet Downgrades Huntsman (HUN) to Neutral Citing MDI Risks
-
G.I.D.C : Three Months to the Elections in Mexico. What Kind of Economy Will Outgoing President Enrique Peña Nieto Leave Behind?
-
Apple (AAPL) iPhone Unit Estimates Cut at Nomura to 221 Million, 'Units Not Yet Low Enough', Lowers FY 2018 EPS Estimate
-
Rally ends for stocks in U.S. retailers; investors shop for bargains
-
Ctrip.com (CTRP) PT Raised to $57 at Nomura/Instinet
-
Sarepta Therapeutics (SRPT) PT Maintained at $96 at Nomura/Instinet Following 'Microdystrophin Dinner with Dr. Rodino-Klapac'
-
Alexion Pharmaceuticals (ALXN) PT Raised to $156 at Nomura/Instinet
-
Solid Biosciences (SLDB) PT Lowered to $37 at Nomura/Instinet Following Announced Clinical Hold
-
Signet Jewelers (SIG) PT Lowered to $45 at Nomura/Instinet on 4Q Report; 'Another Disappointing Report'
-
PayPal (PYPL) PT Raised to $97 at Nomura/Instinet; 'Expanding Margin Profile to Overwhelm EBAY Headwinds'
-
MongoDB (MDB) PT Raised to $31 at Nomura/Instinet
-
Diamond Resorts Tournament of Champions to Kick Off 2019 LPGA Season
-
Square (SQ) Gains as Nomura/Instinet Says 60% of Merchants Willing to Accept Bitcoin
-
Cellectis (CLLS) PT Raised to $73 at Nomura/Instinet on 4Q Report; 'Several Significant 2018 Catalysts'
-
Square (SQ) PT Maintained at $64 at Nomura/Instinet on Merchants Survery; '60% of Merchants Willing to Accept Bitcoin as Payment'
-
Axalta Coating Systems (AXTA) PT Raised to $35 at Nomura/Instinet
-
Ford (F) PT Lowered to $10 at Nomura/Instinet on Higher Steel/Aluminum Prices; 'Large Hit to Earnings'
-
Form 6-K NOMURA HOLDINGS INC For: Mar 13

